This 45 minute module presented by Dr Constantine Tam, provides an overview of the diagnosis and management of Chronic Lymphocytic Leukaemia, including staging, prognostic risk factors and available novel agents for treatment. This module will look at key research studies to provide an understanding of how to manage CLL in the clinic and how to interpret data of new drugs.
Chronic Lymphocytic Leukaemia
AUS
$0
free
Certificate of Completion
45 min
Expired
1 Credits
Course Description
Course Details
Expiry Date: 2021-03-31
Professions: Specialist
Faculty
|
Dr Constantine Tam |
Accreditation
The curriculum is endorsed by the RACP/RCPA Committee for Joint College training in Haematology (CJCT) and the Haematology Society of Australia and New Zealand (HSANZ). Fellows of the RACP may claim CPD hours under the CPD Program (CPDP).
Learning Objective(s)
At the end of this module, you will be better able to:
- Define the
clinical staging, treatment indications and key prognostic factors for CLL - Describe
the mechanisms of action of targeted treatments for CLL and the rationale for
treatment selection in frontline and relapsed or refractory CLL - Discuss
the progression-free survival outcomes for both chemotherapy and newer targeted
treatments used in CLL - Identify
important adverse reactions to treatments used in CLL and strategies for
managing them